Fact CheckerSign in

NCT07519538Active, not recruiting

Southern Sichuan HIV Cohort Study Protocol

Multi-source Data-integrated HIV Cohort in Four Cities of Southern Sichuan, China: a Mixed Retrospective-prospective Study Protocol

Source: ClinicalTrials.gov · Last updated 9 Apr 2026

Brief summary (registry, in English)

Multi-source data-integrated HIV cohort in four cities of southern Sichuan, China: a mixed retrospective-prospective study protocol.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
10 (estimated)
First submitted
2 Apr 2026
Start date
3 Apr 2026
Primary completion date
30 Apr 2027
Lead sponsor
Southwest Medical University
Diseases
HIV
NCT number
NCT07519538

What you commit to

  • Study type: Observational
  • Planned participants: 10
  • From 3 Apr 2026 to the primary completion date, 30 Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Missing key information that cannot be verified or supplemented from original records
  • Unable to complete the questionnaire and no alternative data collection method available
  • Obviously inconsistent or untrustworthy data that cannot be confirmed after verification
  • Not suitable for inclusion under ethical and compliance requirements (e.g., unable to provide consent without a legally authorized representative when required)

Who the study is looking for

  • People living with HIV (PLWH) or AIDS patients who are registered and diagnosed at the participating research centers in Luzhou, Zigong, Neijiang, or Yibin, China
  • Key assessment information (clinical, laboratory, or follow-up data) obtainable during the study period
  • Traceable medical treatment or follow-up records within the retrospective time window (1 January 2019 to 31 December 2025)
  • Able to understand and complete the questionnaire and provide written informed consent (for the prospective component)
  • Residing or visiting within the four southern Sichuan cities, or continuously managed at the local research centers

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Southwest Medical University
Coordinator of this site? Confirm its status
LuzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.